Masayuki Shiseki

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Development of Diffuse Large B-Cell Lymphoma in a Patient with Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma: Clonal Identity between Two B-Cell Neoplasms”.

Development of Diffuse Large B-Cell Lymphoma in a Patient with Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma: Clonal Identity between Two B-Cell Neoplasms

Hematology Reports(2011)10.4081/hr.2011.e10

N/A

0.416DataRank · unranked

15 citations

Akihiro Masuda, Norimichi Watanabe, Masami Fujii, Tomofumi Kimura, Kentaro Yoshinaga +4 more

Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy

International Journal of Clinical Oncology(2017)10.1007/s10147-017-1141-y

N/A

0.241DataRank · unranked

4 citations

Chikashi Yoshida, Naoki Takezako, Akira Ohwada, Takashi Kumagai, Kaichi Nishiwaki +10 more